sulforaphane has been researched along with Sepsis in 5 studies
sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.
Sepsis: Systemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To explore the effects and molecular mechanisms of sulforaphane (SFN) on sepsis-associated inflammation and sarcopenia." | 8.31 | Sulforaphane reduces lipopolysaccharide-induced inflammation and enhances myogenic differentiation of mouse embryonic myoblasts via the toll-like receptor 4 and NLRP3 pathways. ( Gan, L; Liu, M; Teng, Z; Wang, M; Wu, X; Xu, W; Zhang, Y, 2023) |
| "As sepsis is associated with a 50% increase in mortality, sepsis-induced cardiomyopathy has become a critical topic." | 5.91 | Effect of Sulforaphane on cardiac injury induced by sepsis in a mouse model: Role of toll-like receptor 4. ( Altoraihi, K; Ghafil, FA; Hadi, NR; Hadi, SMH; Majeed, S, 2023) |
| "To explore the effects and molecular mechanisms of sulforaphane (SFN) on sepsis-associated inflammation and sarcopenia." | 4.31 | Sulforaphane reduces lipopolysaccharide-induced inflammation and enhances myogenic differentiation of mouse embryonic myoblasts via the toll-like receptor 4 and NLRP3 pathways. ( Gan, L; Liu, M; Teng, Z; Wang, M; Wu, X; Xu, W; Zhang, Y, 2023) |
| "As sepsis is associated with a 50% increase in mortality, sepsis-induced cardiomyopathy has become a critical topic." | 1.91 | Effect of Sulforaphane on cardiac injury induced by sepsis in a mouse model: Role of toll-like receptor 4. ( Altoraihi, K; Ghafil, FA; Hadi, NR; Hadi, SMH; Majeed, S, 2023) |
| "Sepsis is often characterized by an acute brain inflammation and dysfunction, which is associated with increased morbidity and mortality worldwide." | 1.43 | Sulforaphane induces neurovascular protection against a systemic inflammatory challenge via both Nrf2-dependent and independent pathways. ( Alexander, JS; Becker, F; Evans, PC; Gavins, FNE; Gillespie, S; Holloway, PM; Nguyen, V; Vital, SA, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, M | 3 |
| Liu, M | 3 |
| Xu, W | 3 |
| Teng, Z | 3 |
| Wu, X | 3 |
| Gan, L | 3 |
| Zhang, Y | 3 |
| Hadi, SMH | 1 |
| Majeed, S | 1 |
| Ghafil, FA | 1 |
| Altoraihi, K | 1 |
| Hadi, NR | 1 |
| Lee, IC | 1 |
| Kim, DY | 1 |
| Bae, JS | 2 |
| Ku, SK | 1 |
| Han, MS | 1 |
| Holloway, PM | 1 |
| Gillespie, S | 1 |
| Becker, F | 1 |
| Vital, SA | 1 |
| Nguyen, V | 1 |
| Alexander, JS | 1 |
| Evans, PC | 1 |
| Gavins, FNE | 1 |
5 other studies available for sulforaphane and Sepsis
| Article | Year |
|---|---|
Sulforaphane reduces lipopolysaccharide-induced inflammation and enhances myogenic differentiation of mouse embryonic myoblasts via the toll-like receptor 4 and NLRP3 pathways.
Topics: Animals; Cell Differentiation; Inflammasomes; Inflammation; Lipopolysaccharides; Mice; Myoblasts; NL | 2023 |
Sulforaphane reduces lipopolysaccharide-induced inflammation and enhances myogenic differentiation of mouse embryonic myoblasts via the toll-like receptor 4 and NLRP3 pathways.
Topics: Animals; Cell Differentiation; Inflammasomes; Inflammation; Lipopolysaccharides; Mice; Myoblasts; NL | 2023 |
Sulforaphane reduces lipopolysaccharide-induced inflammation and enhances myogenic differentiation of mouse embryonic myoblasts via the toll-like receptor 4 and NLRP3 pathways.
Topics: Animals; Cell Differentiation; Inflammasomes; Inflammation; Lipopolysaccharides; Mice; Myoblasts; NL | 2023 |
Sulforaphane reduces lipopolysaccharide-induced inflammation and enhances myogenic differentiation of mouse embryonic myoblasts via the toll-like receptor 4 and NLRP3 pathways.
Topics: Animals; Cell Differentiation; Inflammasomes; Inflammation; Lipopolysaccharides; Mice; Myoblasts; NL | 2023 |
Sulforaphane reduces lipopolysaccharide-induced inflammation and enhances myogenic differentiation of mouse embryonic myoblasts via the toll-like receptor 4 and NLRP3 pathways.
Topics: Animals; Cell Differentiation; Inflammasomes; Inflammation; Lipopolysaccharides; Mice; Myoblasts; NL | 2023 |
Sulforaphane reduces lipopolysaccharide-induced inflammation and enhances myogenic differentiation of mouse embryonic myoblasts via the toll-like receptor 4 and NLRP3 pathways.
Topics: Animals; Cell Differentiation; Inflammasomes; Inflammation; Lipopolysaccharides; Mice; Myoblasts; NL | 2023 |
Sulforaphane reduces lipopolysaccharide-induced inflammation and enhances myogenic differentiation of mouse embryonic myoblasts via the toll-like receptor 4 and NLRP3 pathways.
Topics: Animals; Cell Differentiation; Inflammasomes; Inflammation; Lipopolysaccharides; Mice; Myoblasts; NL | 2023 |
Sulforaphane reduces lipopolysaccharide-induced inflammation and enhances myogenic differentiation of mouse embryonic myoblasts via the toll-like receptor 4 and NLRP3 pathways.
Topics: Animals; Cell Differentiation; Inflammasomes; Inflammation; Lipopolysaccharides; Mice; Myoblasts; NL | 2023 |
Sulforaphane reduces lipopolysaccharide-induced inflammation and enhances myogenic differentiation of mouse embryonic myoblasts via the toll-like receptor 4 and NLRP3 pathways.
Topics: Animals; Cell Differentiation; Inflammasomes; Inflammation; Lipopolysaccharides; Mice; Myoblasts; NL | 2023 |
Effect of Sulforaphane on cardiac injury induced by sepsis in a mouse model: Role of toll-like receptor 4.
Topics: Animals; Cardiomyopathies; Heart Injuries; Male; Mice; Sepsis; Toll-Like Receptor 4 | 2023 |
Sulforaphane Reduces HMGB1-Mediated Septic Responses and Improves Survival Rate in Septic Mice.
Topics: Animals; Anti-Inflammatory Agents; Brassicaceae; Cell Movement; Disease Models, Animal; HMGB1 Protei | 2017 |
Sulforaphane inhibits endothelial protein C receptor shedding in vitro and in vivo.
Topics: ADAM Proteins; ADAM17 Protein; Animals; Blood Coagulation Factors; Cecum; Disease Models, Animal; Hu | 2014 |
Sulforaphane induces neurovascular protection against a systemic inflammatory challenge via both Nrf2-dependent and independent pathways.
Topics: Adolescent; Adult; Animals; Anti-Inflammatory Agents; Antioxidants; Brain; Cell Line; Disease Models | 2016 |